Zydus Lifesciences has received final clearance from the USFDA for its Deflazacort Oral Suspension (22.75 mg/mL) for the treatment of Duchenne Muscular Dystrophy in patients aged 5 years and older, which is a generic version of Emflaza Oral...
Abbott, a global healthcare leader, has announced the launch of its AVEIR Dual Chamber (DR) leadless pacemaker system. It is the first dual-chamber leadless pacemaker system in the world that is engineered to help the heart beat in a more...
Eli Lilly and Company has revealed a substantial investment in India of up to $1 billion over the next few years to build new contract manufacturing facilities and a new advanced manufacturing and quality hub in Hyderabad. The US pharma company...
AstraZeneca Pharma India has been given the green light by the Central Drugs Standard Control Organisation (CDSCO) to import, market, and distribute Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder, branded as Enhertu.
.jpeg "Pharmexcil Seeks Industry Input on Kuwait Market Access")
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) invites suggestions from Indian pharmaceutical companies for overcoming market access barriers in Kuwait after the formation of the India-Kuwait Joint Working Group
India has moved one step ahead in mosquito control by means of developing the Renofluthrin molecule thus placing India at the front of the world in fighting diseases which are carried by mosquitoes.
In a substantial change, the Union Health Ministry has unveiled comprehensive changes to rates for nearly 2,000 medical procedures under the Central Government Health Scheme (CGHS), the first major revision in rates since 2014...
.png "AbbVie Files FDA Approval for Rare Blood Cancer Therapy")
AbbVie has forwarded a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) that aims to get consent for an experimental treatment, Pivekimab sunirine (PVEK) for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Parexel has entered into a partnership deal with Weave Bio to simplify regulatory filing procedures and shorten the time to market of new treatments.
The suspicion of Coldrif cough syrup contamination has led to Immediate Inspection following reports of child fatalities in Madhya Pradesh and Rajasthan. Drug Controller General of India (DCGI) Dr Rajivsingh Reghuvanshi ordered an inspection...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")